Cart
sales@molnova.com
Anemosapogenin
CAS No. 85999-40-2
Anemosapogenin( —— )
Catalog No. M19185 CAS No. 85999-40-2
Anemosapogenin shows potent anti-tumor effect in vivo, but it has some toxicity, structure modification should be needed.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 74 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAnemosapogenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnemosapogenin shows potent anti-tumor effect in vivo, but it has some toxicity, structure modification should be needed.
-
DescriptionAnemosapogenin shows potent anti-tumor effect in vivo, but it has some toxicity, structure modification should be needed.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number85999-40-2
-
Formula Weight472.71
-
Molecular FormulaC30H48O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (211.55 mM)
-
SMILESCC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)O)C)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor(IC50 :1.9 nM). AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
-
MS-PPOH
MS-PPOH is a potent and selective inhibitor of cytochrome P450 (CYP) epoxygenase, specifically inhibiting CYP2C8 and CYP2C9 with IC50 values of 15 and 11 μM, respectively.
-
Diosmetin
Diosmetin is an O-methylated flavone, a chemical compound that can be found in the Caucasian vetch.
